Internal Medicine, Nephrology · Visalia, CA
NPI
1467618363
Since 2008
Specialty
Internal Medicine, Nephrology
Code 207RN0300X
Group practices
1
Medicare group memberships
Hospitals
4
Hospital affiliations
1700 S Court St, Suite D
Visalia, CA, 93277
Phone (559) 697-6290
Groups this clinician bills Medicare through
Medicare paid, 2024
$667K
8,006 services
Medicare patients, 2024
500
Average age 74
Drug cost, 2024
$1.3M
6,377 prescriptions
Company payments, 2025
$1,518
From 18 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Yasser W Barsoum was code 99214 (office e&m - established), 2,686 times for 460 patients. In total Yasser W Barsoum billed 8,006 services in 21 codes, and Medicare paid $667K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2017-03-17.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 2,686 | 460 | $108.67 | $292K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 2,026 | 451 | $13.74 | $28K |
| 99233 Hospital E&M - Subsequent | Facility | 806 | 106 | $99.36 | $80K |
| 90960 ESRD Related Services (not dialysis) | Office | 350 | 43 | $297.74 | $104K |
| 99458 E&M - Miscellaneous | Office | 346 | 109 | $34.48 | $12K |
| 99457 E&M - Miscellaneous | Office | 262 | 116 | $43.26 | $11K |
| 99439 Chronic, Principal, and Transitional Care Management | Office | 245 | 61 | $42.15 | $10K |
| 99223 Hospital E&M - Initial | Facility | 236 | 135 | $142.69 | $34K |
| 90961 ESRD Related Services (not dialysis) | Office | 205 | 30 | $245.77 | $50K |
| 99232 Hospital E&M - Subsequent | Facility | 205 | 37 | $65.93 | $14K |
| 99211 Office E&M - Established | Office | 137 | 25 | $21.04 | $2,882 |
| 99454 E&M - Miscellaneous | Office | 131 | 85 | $43.70 | $5,725 |
| 99490 Chronic, Principal, and Transitional Care Management | Office | 115 | 58 | $54.76 | $6,297 |
| 99453 E&M - Miscellaneous | Office | 83 | 83 | $18.23 | $1,513 |
| 99204 Office E&M - New | Office | 82 | 82 | $141.19 | $12K |
By year: 2022 $649K for 5,578 services; 2023 $570K for 5,089 services; 2024 $667K for 8,006 services.
Medicare prescription drug claims, 2024
In 2024, the drug Yasser W Barsoum prescribed most often to Medicare patients was Atorvastatin Calcium, with 417 prescriptions and refills. In total Yasser W Barsoum wrote 6,377 Medicare prescriptions that cost $1.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 417 | 1,101 | 148 | $3,542 |
| Lisinopril Generic | 253 | 689 | 98 | $2,510 |
| Levothyroxine Sodium Generic | 224 | 584 | 71 | $2,760 |
| Alprazolam Generic | 220 | 220 | 65 | $857 |
| Bumetanide Generic | 177 | 426 | 71 | $7,256 |
| Prosol Parenteral Amino Acid 20% No.1 | 172 | 172 | Under 11 | $28K |
| Amlodipine Besylate Generic | 168 | 432 | 58 | $1,000 |
| Calcitriol Generic | 140 | 390 | 66 | $3,099 |
| Cinacalcet Hcl Generic | 137 | 327 | 46 | $23K |
| Ozempic Semaglutide | 134 | 165 | 28 | $139K |
| Clinolipid Fat Emulsion/Olive/Soy/Phospho | 133 | 133 | Under 11 | $47K |
| Hydralazine Hcl Generic | 132 | 346 | 49 | $2,131 |
| Losartan Potassium Generic | 124 | 319 | 38 | $1,127 |
| Sevelamer Carbonate Generic | 122 | 230 | 42 | $38K |
| Carvedilol Generic | 119 | 334 | 40 | $1,160 |
Brand drugs: 1,244 claims; generic drugs: 5,072 claims; opioid claims: 94.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Yasser W Barsoum $1,518 ($1,518 in general payments such as food, travel and fees) from 18 companies. The largest payer was Ardelyx, Inc. with $258.
| Company | Payments | Amount |
|---|---|---|
| Ardelyx, Inc. ARDX | 18 | $258 |
| Amgen Inc. AMGN | 20 | $217 |
| Mallinckrodt Hospital Products Inc. | 7 | $166 |
| Fresenius USA Marketing, Inc. | 10 | $152 |
| Novo Nordisk Inc NVO | 5 | $120 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 4 | $88.69 |
| Akebia Therapeutics Inc AKBA | 3 | $82.44 |
| Lilly USA, LLC LLY | 3 | $63.99 |
| Calliditas Therapeutics US Inc. | 2 | $60.5 |
| ANI Pharmaceuticals, Inc. ANIP | 2 | $57.01 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.